MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated Retained Earnings 2011-2026 | ARAY
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -519 M | -518 M | -502 M | -493 M | -488 M | -482 M | -486 M | -474 M | -450 M | -421 M | -395 M | -355 M | -320 M | -216 M | -144 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -144 M | -519 M | -418 M |
Quarterly Retained Earnings Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -555 M | -541 M | -519 M | -520 M | -519 M | -522 M | -518 M | -521 M | -515 M | -505 M | -502 M | -500 M | -500 M | -498 M | -493 M | -489 M | -488 M | -488 M | -488 M | -488 M | -477 M | -481 M | -482 M | -482 M | -484 M | -495 M | -486 M | -486 M | -483 M | -478 M | -474 M | -474 M | -464 M | -460 M | -450 M | -450 M | -440 M | -431 M | -421 M | -421 M | -414 M | -408 M | -395 M | -395 M | -387 M | -377 M | -355 M | -355 M | -341 M | -335 M | -320 M | -320 M | -270 M | -241 M | -216 M | -216 M | -181 M | -171 M | -144 M | -144 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -144 M | -555 M | -425 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.98 | -2.99 % | $ 1.75 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 25.43 | -1.2 % | $ 215 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.34 | 0.91 % | $ 125 M |  France |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.63 | 5.0 % | $ 39.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 10.45 | -5.68 % | $ 296 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 89.09 | -1.79 % | $ 12 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.98 | -4.81 % | $ 1.2 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.24 | 0.82 % | $ 50.5 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.92 | -4.47 % | $ 1.04 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.67 | -2.02 % | $ 462 M |  Curacao |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.01 | -0.89 % | $ 352 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.28 | -2.56 % | $ 368 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 178.09 | -2.61 % | $ 12.5 B | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.04 | - | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 35.77 | -2.77 % | $ 1.11 B | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 59.04 | -3.67 % | $ 3.22 B |  Britain |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 53.55 | -2.8 % | $ 1.57 B | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.35 | - | $ 64 M | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.13 | -0.93 % | $ 5.91 M | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 83.44 | -1.46 % | $ 2.9 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.47 | -0.98 % | $ 47.6 B | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.79 | 1.28 % | $ 37.1 M | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 22.81 | -3.22 % | $ 522 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 313.4 | -2.52 % | $ 120 B | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 100.97 | -0.29 % | $ 3.43 B | USA |